Bloomberg | Leading Cancer Center No Longer Offering Zantac to Patients

Bloomberg published an article titled, "Leading Cancer Center No Longer Offering Zantac to Patients." The article highlights Valisure's detections of NDMA in Zantac pills and its generics.

View the article via Bloomberg here.

View Other Newsroom Posts

Bloomberg | Leading Cancer Center No Longer Offering Zantac to Patients

October 2, 2019

Bloomberg published an article titled, "Leading Cancer Center No Longer Offering Zantac to Patients." The article highlights Valisure's detections of NDMA in Zantac pills and its generics.

View the article via Bloomberg here.

View Other Newsroom Posts

Bloomberg | Leading Cancer Center No Longer Offering Zantac to Patients

Bloomberg published an article titled, "Leading Cancer Center No Longer Offering Zantac to Patients." The article highlights Valisure's detections of NDMA in Zantac pills and its generics.

View the article via Bloomberg here.

Bloomberg published an article titled, "Leading Cancer Center No Longer Offering Zantac to Patients." The article highlights Valisure's detections of NDMA in Zantac pills and its generics.

View the article via Bloomberg here.

View Other Newsroom Posts